Cargando…
Subthreshold microsecond laser for proliferative diabetic retinopathy: a randomized pilot study
AIM: To compare the outcomes of subthreshold microsecond (STM) and continuous-wave laser (CWL) panretinal photocoagulation (PRP). METHODS: In this randomized, prospective, pilot study, 20 eyes of 10 subjects with symmetric severe non-proliferative (NPDR) or low-risk proliferative diabetic retinopath...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774491/ https://www.ncbi.nlm.nih.gov/pubmed/29391774 http://dx.doi.org/10.2147/OPTH.S143206 |
_version_ | 1783293767508295680 |
---|---|
author | Jhingan, Mahima Goud, Abhilash Peguda, Hari Kumar Khodani, Mitali Luttrull, Jeffrey K Chhablani, Jay |
author_facet | Jhingan, Mahima Goud, Abhilash Peguda, Hari Kumar Khodani, Mitali Luttrull, Jeffrey K Chhablani, Jay |
author_sort | Jhingan, Mahima |
collection | PubMed |
description | AIM: To compare the outcomes of subthreshold microsecond (STM) and continuous-wave laser (CWL) panretinal photocoagulation (PRP). METHODS: In this randomized, prospective, pilot study, 20 eyes of 10 subjects with symmetric severe non-proliferative (NPDR) or low-risk proliferative diabetic retinopathy (PDR) were included. Each eye of the subject was randomized into either CWL or STM PRP group. Patients were evaluated at baseline and at months 3, 6, and 9 with color fundus photographs and visual field tests at each visit; however, electroretinography (ERG) was conducted at baseline and at month 9. The primary outcome measure was the difference in disease progression between the groups. Secondary outcome measures included change in visual acuity, contrast visual acuity, retinal sensitivity on visual field test, and change in ERG parameters. RESULTS: During the 9-month follow-up, one eye of the STM group progressed to vitreous hemorrhage at the month 6 follow-up and required rescue conventional laser. The CWL group showed a drop in low-contrast visual acuity, visual field index, and scotopic b/a ratio in comparison to the STM group, although the difference was statistically insignificant (p>0.05). CONCLUSION: This prospective pilot study proposes microsecond PRP is non-inferior to CWL PRP and could be an alternative to CWL PRP to avoid associated complications in cases of severe NPDR and early PDR. |
format | Online Article Text |
id | pubmed-5774491 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57744912018-02-01 Subthreshold microsecond laser for proliferative diabetic retinopathy: a randomized pilot study Jhingan, Mahima Goud, Abhilash Peguda, Hari Kumar Khodani, Mitali Luttrull, Jeffrey K Chhablani, Jay Clin Ophthalmol Original Research AIM: To compare the outcomes of subthreshold microsecond (STM) and continuous-wave laser (CWL) panretinal photocoagulation (PRP). METHODS: In this randomized, prospective, pilot study, 20 eyes of 10 subjects with symmetric severe non-proliferative (NPDR) or low-risk proliferative diabetic retinopathy (PDR) were included. Each eye of the subject was randomized into either CWL or STM PRP group. Patients were evaluated at baseline and at months 3, 6, and 9 with color fundus photographs and visual field tests at each visit; however, electroretinography (ERG) was conducted at baseline and at month 9. The primary outcome measure was the difference in disease progression between the groups. Secondary outcome measures included change in visual acuity, contrast visual acuity, retinal sensitivity on visual field test, and change in ERG parameters. RESULTS: During the 9-month follow-up, one eye of the STM group progressed to vitreous hemorrhage at the month 6 follow-up and required rescue conventional laser. The CWL group showed a drop in low-contrast visual acuity, visual field index, and scotopic b/a ratio in comparison to the STM group, although the difference was statistically insignificant (p>0.05). CONCLUSION: This prospective pilot study proposes microsecond PRP is non-inferior to CWL PRP and could be an alternative to CWL PRP to avoid associated complications in cases of severe NPDR and early PDR. Dove Medical Press 2018-01-15 /pmc/articles/PMC5774491/ /pubmed/29391774 http://dx.doi.org/10.2147/OPTH.S143206 Text en © 2018 Jhingan et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Jhingan, Mahima Goud, Abhilash Peguda, Hari Kumar Khodani, Mitali Luttrull, Jeffrey K Chhablani, Jay Subthreshold microsecond laser for proliferative diabetic retinopathy: a randomized pilot study |
title | Subthreshold microsecond laser for proliferative diabetic retinopathy: a randomized pilot study |
title_full | Subthreshold microsecond laser for proliferative diabetic retinopathy: a randomized pilot study |
title_fullStr | Subthreshold microsecond laser for proliferative diabetic retinopathy: a randomized pilot study |
title_full_unstemmed | Subthreshold microsecond laser for proliferative diabetic retinopathy: a randomized pilot study |
title_short | Subthreshold microsecond laser for proliferative diabetic retinopathy: a randomized pilot study |
title_sort | subthreshold microsecond laser for proliferative diabetic retinopathy: a randomized pilot study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774491/ https://www.ncbi.nlm.nih.gov/pubmed/29391774 http://dx.doi.org/10.2147/OPTH.S143206 |
work_keys_str_mv | AT jhinganmahima subthresholdmicrosecondlaserforproliferativediabeticretinopathyarandomizedpilotstudy AT goudabhilash subthresholdmicrosecondlaserforproliferativediabeticretinopathyarandomizedpilotstudy AT pegudaharikumar subthresholdmicrosecondlaserforproliferativediabeticretinopathyarandomizedpilotstudy AT khodanimitali subthresholdmicrosecondlaserforproliferativediabeticretinopathyarandomizedpilotstudy AT luttrulljeffreyk subthresholdmicrosecondlaserforproliferativediabeticretinopathyarandomizedpilotstudy AT chhablanijay subthresholdmicrosecondlaserforproliferativediabeticretinopathyarandomizedpilotstudy |